NEW YORK (GenomeWeb News) – Accelr8 Technology’s fiscal first-quarter revenues plummeted to $8,304 from $202,008 a year ago, the company disclosed in a regulatory document today.

For the three months ended Oct. 31, the biggest year-over-year drop in revenues was in technical development fees due to the conclusion of certain programs last year. The firm had no revenues from such programs in the recently completed quarter compared to $140,000 a year ago, it said in a Form 10-Q filed with the US Securities and Exchange Commission.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.

People around the globe took to the streets to support science — some with signs.

Parents who learn of their increased genetic risk of disease also contend with telling their children about theirs, the New York Times writes.

In PLOS this week: loci linked to body mass index measurements, long non-coding RNA expression and urothelial carcinoma prognosis, and more.